BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia
Yafeng Zhou(Soochow University), Wee Joo Chng(National University Health System)
Cited by 17
Related Papers
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
|Blood|2011|212
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
|Journal of Hematology & Oncology|2017|75
PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms
|Oncotarget|2015|50
A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase
|Journal of Hematology & Oncology|2018|39